Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) Biotest AG: Delisting agreement and announced delisting tender offer eieich, March 31, 2025: Biotest AG (ISIN ...

EQS-News: Biotest AG / Key word (s): Annual Report Biotest AG increases sales by 6% in financial year 2024 31.03.2025 / 07:00 CET/CEST The issuer is solely responsible for the content of this ...

Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols SA to shareholders of Biotest.

The Spanish company’s Biotest subsidiary has reported top-line results of the phase 3 AdFirst trial of the concentrated preparation of fibrinogen, called BT524, which show it is at least as ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols S.A. to shareholders of Biotest: Biotest AG Attn.